限制性股票激励计划
Search documents
亿道信息: 关于2025年限制性股票激励计划内幕信息知情人及激励对象买卖公司股票情况的自查报告
Zheng Quan Zhi Xing· 2025-09-05 11:12
Core Viewpoint - The company conducted a self-examination regarding insider trading related to its 2025 Restricted Stock Incentive Plan, confirming that no insider trading occurred among the relevant parties during the specified period [1][3]. Group 1: Self-Examination Process - The self-examination covered the period from February 18, 2025, to August 18, 2025, focusing on stock trading activities of insider information personnel and incentive recipients [1]. - The examination was conducted in accordance with the relevant laws and regulations, with verification from the China Securities Depository and Clearing Corporation [1]. Group 2: Trading Activities of Insiders - During the self-examination period, only one entity, Guotai Junan Securities Co., Ltd., was found to have engaged in stock trading, while other insider information personnel did not engage in any trading activities [2]. - A total of 25 incentive recipients were identified to have traded the company's stock, but they acted based on publicly available information and independent judgment [2][3]. Group 3: Conclusion of Self-Examination - The company confirmed that appropriate confidentiality measures were in place during the planning and discussion of the incentive plan, and no insider trading was detected among the relevant parties [3]. - The findings align with the regulations set forth in the Management Measures for Equity Incentives, indicating no violations of insider trading laws [3].
南京聚隆: 薪酬与考核委员会关于2025年第二期限制性股票激励计划首次授予激励对象名单(截至授予日)的核查意见
Zheng Quan Zhi Xing· 2025-09-05 11:12
Core Points - The company has reviewed and approved the list of incentive recipients for the 2025 Second Phase Restricted Stock Incentive Plan, confirming that all recipients meet the necessary legal and regulatory requirements [1][2] - The initial grant date for the incentive plan is set for September 5, 2025, with a price of 12.96 yuan per share for a total of 635,000 shares to be granted to 10 eligible recipients [2] Summary by Sections Incentive Plan Overview - The 2025 Second Phase Restricted Stock Incentive Plan has been established in accordance with relevant laws and regulations, including the Company Law and Securities Law of the People's Republic of China [1] - The plan aims to incentivize key management personnel and core staff, excluding independent directors, foreign employees, and major shareholders [2] Eligibility Criteria - The company has confirmed that all selected incentive recipients comply with the conditions outlined in the Management Measures and Listing Rules, ensuring their eligibility for the incentive plan [2] - Specific disqualifications for potential recipients include recent sanctions by the securities exchange or regulatory bodies, major legal violations, and other conditions as defined by law [1] Grant Details - The board and the remuneration committee have agreed on the legitimacy and effectiveness of the recipient list, with the conditions for the initial grant being fulfilled [2] - The total number of shares to be granted is 635,000, distributed among 10 recipients at a price of 12.96 yuan per share [2]
特宝生物: 特宝生物:关于调整2024年限制性股票激励计划授予价格的公告
Zheng Quan Zhi Xing· 2025-09-05 11:12
Core Viewpoint - The company has adjusted the grant price of the 2024 restricted stock incentive plan from 39.80 CNY per share to 39.18 CNY per share due to the implementation of the annual profit distribution plan [5][6][7]. Group 1: Decision-Making Process - The board of directors and the supervisory board approved the adjustment of the grant price during their respective meetings held on September 4, 2025 [1][5]. - The adjustment follows the procedures outlined in the company's 2024 restricted stock incentive plan draft and was authorized by the shareholders at the first extraordinary general meeting of 2024 [2][3]. Group 2: Adjustment Details - The adjustment was made based on the profit distribution plan approved at the 2024 annual general meeting, which included a cash dividend of 0.62 CNY per share [6]. - The formula used for the adjustment is P = P0 - V, where P0 is the original grant price, V is the cash dividend per share, and P is the adjusted grant price [6]. Group 3: Impact of Adjustment - The adjustment of the grant price is a result of the annual profit distribution and will not have a substantial impact on the company's financial status or operating results [6][7]. - The supervisory board confirmed that the adjustment complies with relevant regulations and does not harm the interests of the company or its shareholders [7]. Group 4: Legal Opinions - The company has obtained necessary approvals for the adjustment, ensuring compliance with relevant regulations and guidelines [7][8]. - The conditions for the reserved portion of the incentive plan have been met, and the company will continue to fulfill its information disclosure obligations as the incentive plan progresses [8].
南京聚隆: 关于向2025年第二期限制性股票激励计划激励对象首次授予限制性股票的公告
Zheng Quan Zhi Xing· 2025-09-05 11:12
证券代码:300644 证券简称:南京聚隆 公告编号:2025-102 债券代码:123209 债券简称:聚隆转债 南京聚隆科技股份有限公司 关于向 2025 年第二期限制性股票激励计划激励对象 首次授予限制性股票的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示: ? 限制性股票首次授予数量:63.50 万股 ? 限制性股票首次授予价格:12.96 元/股 ? 股权激励方式:第二类限制性股票 南京聚隆科技股份有限公司(以下简称"公司")2025 年第二期限制性股票 激励计划规定的限制性股票首次授予条件已成就,根据公司 2025 年第二次临时 股东大会的授权,公司于 2025 年 9 月 5 日召开了第六届董事会第十七次会议, 会议审议通过了《关于向 2025 年第二期限制性股票激励计划激励对象首次授予 限制性股票的议案》,确定以 2025 年 9 月 5 日为首次授予日,向 10 名激励对象 授予限制性股票 63.50 万股,授予价格为 12.96 元/股。现将有关事项说明如下: 一、激励计划简述 (一)激励工具:第二类限制性股票 (二)标 ...
特宝生物: 特宝生物:第九届董事会第十一次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 11:12
证券代码:688278 证券简称:特宝生物 公告编号:2025-029 厦门特宝生物工程股份有限公司 第九届董事会第十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 厦门特宝生物工程股份有限公司(以下简称"公司")第九届董事会第十一 次会议于 2025 年 9 月 4 日以现场会议结合通讯表决的方式召开。全体董事一致 同意豁免本次会议通知的期限要求,并已在董事会会议上就豁免通知时限的相关 情况做出说明。本次会议由董事长孙黎先生主持,会议应出席董事 9 名,实际出 席董事 9 名,董事会秘书、部分监事及其他高级管理人员列席本次会议。本次会 议的召集和召开程序符合《公司法》和《公司章程》等有关规定,会议决议合法、 有效。 二、董事会会议审议情况 (一)审议通过《关于调整 2024 年限制性股票激励计划授予价格的议案》 鉴于公司 2024 年年度权益分派方案已于 2025 年 5 月 9 日实施完毕,以方案 实施前的公司总股本 406,800,000 股为基数,每股派发现金红利 0.62 ...
特宝生物: 特宝生物:第九届监事会第八次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 11:12
证券代码:688278 证券简称:特宝生物 公告编号:2025-030 厦门特宝生物工程股份有限公司 第九届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 部分限制性股票的议案》 经认真审议,监事会认为: 规定的禁止实施股权激励计划的情形,公司具备实施股权激励计划的主体资格。 人民共和国证券法》等法律、法规和规范性文件规定的任职资格,符合《上市 公司股权激励管理办法》及《上海证券交易所科创板股票上市规则》规定的激 励对象条件,符合公司《2024 年限制性股票激励计划(草案)》及其摘要规定 的激励对象范围,其作为公司 2024 年限制性股票激励计划预留授予激励对象的 主体资格合法、有效。 以及公司《2024 年限制性股票激励计划(草案)》及其摘要中有关授予日的相 关规定。 厦门特宝生物工程股份有限公司(以下简称"公司")第九届监事会第八 次会议于 2025 年 9 月 4 日以现场结合通讯表决的方式召开。经全体监事同意, 一致豁免本次会议通知的期限要求,并已在会议上就豁免通知 ...
汇通集团: 汇通集团第二届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-09-05 10:17
债券代码:113665 债券简称:汇通转债 汇通建设集团股份有限公司 第二届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承 担法律责任。 一、监事会会议召开情况 证券代码:603176 证券简称:汇通集团 公告编号:2025-062 价格的议案》 监事会认为:公司调整2025年限制性股票激励计划预留授予价格, 符合《上市公司股权激励管理办法》等法律法规、规范性文件和《汇 通建设集团股份有限公司2025年限制性股票激励计划(草案)》中相 关调整事项的规定。本次调整在公司2025年第一次临时股东大会对公 司董事会的授权范围内,程序合法、合规,不存在损害公司及全体股 东利益的情形。本次调整合法、有效,同意本次对公司限制性股票预 留授予价格的调整安排。 表决结果:3票同意、0票反对、0票弃权,议案获通过。 予预留部分限制性股票的议案》 根据《上市公司股权激励管理办法》、《汇通建设集团股份有限 公司2025年限制性股票激励计划(草案)》的相关规定以及公司2025 年第一次临时股东大会的授权,公司监事会认为公司2025年限 ...
久祺股份: 董事会薪酬与考核委员会关于2025年限制性股票激励计划激励对象名单的公示情况说明及核查意见
Zheng Quan Zhi Xing· 2025-09-05 09:17
Core Viewpoint - The company has announced the public disclosure and verification opinions regarding the 2025 Restricted Stock Incentive Plan, which was approved by the board of directors on August 25, 2025 [1]. Disclosure Situation - The public disclosure includes the names and positions of the incentive plan participants [2] - The disclosure period is from August 27, 2025, to September 5, 2025 [2] - The disclosure method is through the company's public bulletin board [2] - Employees can provide feedback in writing or via email during the disclosure period [2] - No objections were received regarding the proposed list of incentive participants by the end of the disclosure period [2] Verification Situation - The board's remuneration and assessment committee verified the list of proposed incentive participants, including their identification documents, employment contracts, and positions within the company [2][3] Verification Opinions - The incentive participants meet the qualifications as stipulated by the Company Law, Securities Law, Management Measures, Listing Rules, and other relevant regulations [3] - The proposed participants do not fall under any disqualifying conditions as per the Management Measures [3] - The participants include core technical/business personnel and other individuals deemed necessary for incentives, excluding independent directors and major shareholders [3] - The basic information of the incentive participants is accurate, with no falsehoods or significant omissions [3]
艾比森:9月23日将召开2025年第三次临时股东大会
Zheng Quan Ri Bao Wang· 2025-09-05 07:17
Group 1 - The company, Absen (300389), announced that it will hold its third extraordinary general meeting of shareholders on September 23, 2025 [1] - The agenda for the meeting includes the review of the proposal regarding the "Draft of the 2025 Restricted Stock Incentive Plan and its Summary" [1]
广东朝阳电子科技股份有限公司 2025年第二次临时股东大会决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-05 05:02
Meeting Details - The second extraordinary general meeting of shareholders was held on September 4, 2025, at 14:30 [2] - The meeting combined on-site voting and online voting, with specific time slots for each [3][5] - The meeting was hosted by director Xu Linzhe due to the absence of the chairwoman Guo Liqin [6] Attendance - A total of 190 shareholders and authorized representatives attended, representing 91,573,164 shares, which is 67.7050% of the total voting shares [7] - Among them, 5 attended the on-site meeting, representing 91,114,800 shares (67.3661%), while 185 participated via online voting, representing 458,364 shares (0.3389%) [7] Resolutions Passed - The following proposals were approved at the meeting: 1. The proposal regarding the "2025 Restricted Stock Incentive Plan (Draft)" was passed with over two-thirds approval from non-related shareholders [10] 2. The proposal concerning the "Implementation Assessment Management Measures for the 2025 Restricted Stock Incentive Plan" was also passed with similar support [10] 3. The proposal to authorize the board of directors to handle matters related to the 2025 Restricted Stock Incentive Plan was approved [11] Legal Opinions - The legal representatives from Shanghai Jintiancheng (Guangzhou) Law Firm confirmed that the meeting's procedures complied with relevant laws and regulations [12] Rental Agreement Termination - The company terminated the rental contract with Dongguan Yihong Property Investment Co., Ltd. due to serious breaches, including rent arrears [23][24] - The rental contract was originally signed on July 1, 2024, for a period of three years, with a total rent of 9.1836 million yuan [24] - The company has filed a lawsuit to recover approximately 1.781 million yuan in unpaid rent and related fees [24][25] Impact of Contract Termination - The termination of the rental agreement is not expected to significantly impact the company's normal operations and ongoing development [25] - The company will continue to monitor the situation and take necessary measures to protect its legal rights [25]